Ge Long Hui·2025-11-28 08:47Core Viewpoint - The company, Baiyunshan (00874.HK), has announced a transaction involving the sale of additional underlying assets to Xingzheng Asset Management for a total purchase price of RMB 440,280,622.20, aimed at enhancing liquidity through asset securitization [1] Group 1: Transaction Details - Baiyunshan's non-wholly owned subsidiary, Guangzhou Pharmaceutical, signed a "New Underlying Asset Delivery Confirmation" with Xingzheng Asset Management based on the asset sale agreement (Phase IV) [1] - The transaction involves the sale of the fifth batch of additional underlying assets, confirming the financial terms and conditions of the deal [1] Group 2: Financial Implications - The transaction allows Guangzhou Pharmaceutical to utilize accounts receivable for asset securitization, converting receivables into more liquid cash assets [1] - The board of directors considers the terms of the transaction to be fair and reasonable, aligning with the overall interests of the group and its shareholders [1]